NCT04422093 (OK) is a clinical trial of OrthoKontrol in Medical Device Complication, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT04422093?

NCT04422093 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT04422093?

Interventions in NCT04422093: OrthoKontrol.

What condition does NCT04422093 study?

NCT04422093 studies Medical Device Complication.

Is NCT04422093 still recruiting?

NCT04422093 is currently withdrawn. Last updated 13 April 2025.

Last reviewed 2025-04-13 · How we verify

NCT04422093: OK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Monitoring System for the Wearing of Orthodontic Elastics

Withdrawn Last updated 13 April 2025

What this trial tests

trial testing OrthoKontrol in Medical Device Complication. Withdrawn.

Timeline

15 September 2021

Primary endpoint
15 September 2023

15 September 2023

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	15 September 2021
Primary completion	15 September 2023
Estimated completion	15 September 2023
Sites	1 location across Switzerland

Drugs / interventions tested

OrthoKontrol

Conditions studied

Medical Device Complication — all drugs for Medical Device Complication →

Sponsor

University Hospital, Basel, Switzerland

Who can join

11 and older, any sex, with Medical Device Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to validate a novel sensor intended to measure the wearing time of orthodontic elastics in patients with multibracket appliances. The newly developped sensor will be tested in 42 patients over a period of 6 months

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04422093 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04422093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing